Literature DB >> 2215906

Cranial MRI in Wilson's disease.

L Prayer1, D Wimberger, J Kramer, G Grimm, W Oder, H Imhof.   

Abstract

Thirty-eight patients with biochemically proven Wilson's disease underwent magnetic resonance-imaging (MRI) of the brain as well as neurological examinations. The patients were scanned using spin-echo (SE) sequences; the neurologist was looking for typical symptoms: dysarthria, tremor, ataxia, rigidity/bradykinesia and chorea/dystonia. Pathological MR findings believed secondary to this uncommon inherited disorder of copper metabolism were found in twenty-two subjects. Focal abnormalities were seen in the lenticular, thalamic and caudate nuclei as well as in brain stem and white matter; these lesions were best demonstrated on T2-weighted sequences as hyperintense areas. In eight patients we found diffuse brain atrophy with consecutive widening of the ventricular system. Five subjects showed mild, nineteen severe neurologic deficits. Generally there was no correlation between MR findings and clinical neurological symptoms; the impairment of cell-metabolism causing functional alterations of the brain precedes morphological changes. During treatment with the copper chelator D-penicillamine there seemed to be a phased course of disease. Shortening of T1-relaxation due to paramagnetic influence of copper was not seen; a possible explanation could be intracellular deposition--a proton-electron-dipolar-dipolar-interaction would therefore be impossible.

Entities:  

Mesh:

Year:  1990        PMID: 2215906     DOI: 10.1007/bf00589114

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  12 in total

1.  Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study.

Authors:  A De Volder; C J Sindic; A M Goffinet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

2.  [Computer tomographic studies in Wilson disease].

Authors:  W A Nix; G Ludwig; H Backmund
Journal:  Nervenarzt       Date:  1984-10       Impact factor: 1.214

3.  Nuclear magnetic resonance (NMR) imaging in Wilson disease.

Authors:  G A Lawler; J M Pennock; R E Steiner; W J Jenkins; S Sherlock; I R Young
Journal:  J Comput Assist Tomogr       Date:  1983-02       Impact factor: 1.826

4.  Wilson disease of the brain: MR imaging.

Authors:  A M Aisen; W Martel; T O Gabrielsen; G M Glazer; G Brewer; A B Young; G Hill
Journal:  Radiology       Date:  1985-10       Impact factor: 11.105

5.  [Nuclear magnetic resonance tomography and computed tomography of the brain for detection of Wilson's disease].

Authors:  D Uhlenbrock; A Straube; H K Beyer; H C Leopold
Journal:  Digitale Bilddiagn       Date:  1985-09

6.  Improvement of cerebral CT abnormalities following liver transplantation in a patient with Wilson disease.

Authors:  W E Rothfus; W L Hirsch; J J Malatack; I Bergman
Journal:  J Comput Assist Tomogr       Date:  1988 Jan-Feb       Impact factor: 1.826

7.  High-field magnetic resonance imaging of Wilson's disease.

Authors:  J De Haan; R I Grossman; L Civitello; D B Hackney; H I Goldberg; L T Bilaniuk; R A Zimmerman
Journal:  J Comput Tomogr       Date:  1987-04

8.  Wilson's disease studied with FDG and positron emission tomography.

Authors:  R A Hawkins; J C Mazziotta; M E Phelps
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

9.  Wilson's disease: evoked potentials and computed tomography.

Authors:  E S Roach; C S Ford; E V Spudis; A R Riela; W T McLean; J Gilliam; M R Ball
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

10.  Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.

Authors:  S Starosta-Rubinstein; A B Young; K Kluin; G Hill; A M Aisen; T Gabrielsen; G J Brewer
Journal:  Arch Neurol       Date:  1987-04
View more
  28 in total

1.  Wilson's disease: cranial MRI observations and clinical correlation.

Authors:  S Sinha; A B Taly; S Ravishankar; L K Prashanth; K S Venugopal; G R Arunodaya; M K Vasudev; H S Swamy
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

2.  Dopamine D2 receptor binding is reduced in Wilson's disease: correlation of neurological deficits with striatal 123I-iodobenzamide binding.

Authors:  W Oder; T Brücke; H Kollegger; J Spatt; S Asenbaum; L Deecke
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  Neuroimaging in Wilson disease.

Authors:  H N van Wassenaer-van Hall
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

Review 4.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

5.  Cranial MRI in chronic thinner intoxication.

Authors:  R Ashikaga; Y Araki; K Miura; O Ishida
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

6.  Wilson's disease: neurological and magnetic resonance imaging improvement on zinc treatment.

Authors:  J M Heckmann; R W Eastman; J C De Villiers; R Hewlett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

7.  The claustrum on MRI: normal anatomy, and the bright claustrum as a new sign in Wilson's disease.

Authors:  R N Sener
Journal:  Pediatr Radiol       Date:  1993

8.  Wilson's disease: MRI with clinical correlation.

Authors:  A C Magalhaes; P Caramelli; J R Menezes; L S Lo; L A Bacheschi; E R Barbosa; L A Rosemberg; A Magalhaes
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

9.  Fine motor skills disorders in the course of Wilson's disease.

Authors:  Peter Albrecht Günther; Hans-Juergen Kühn; Thomas Villmann; Wieland Hermann
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

10.  Magnetic resonance imaging of the brain in Wilson's disease.

Authors:  H Nazer; J Brismar; M Z al-Kawi; T S Gunasekaran; K H Jorulf
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.